FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1971728260> ?p ?o ?g. }

• W1971728260 endingPage "e12" @default.
• W1971728260 startingPage "e1" @default.
• W1971728260 abstract "The prevalence of type 2 diabetes mellitus is high among the elderly population. Treatment of elderly patients with type 2 diabetes presents challenges because of co-morbidities and the potential increase in the risk of adverse effects. Hyperlipidaemia is also common in the elderly population. Glucose- and lipid-lowering treatment in elderly patients should be individualized on the basis of the patient's life expectancy, health status and cardiovascular risk factors, and evidence-based guideline recommendations. Because elderly patients often have impaired renal and hepatic function, careful considerations must be made when selecting appropriate glucose- and lipid-lowering therapy. There are a number of potential safety issues associated with various glucose- and lipid-lowering therapies that are relevant to elderly patients, including increased risk of heart failure exacerbations, weight loss, increased risk of hypoglycaemia, increased risk of myopathy, and contraindications of some agents in patients with hepatic or renal impairment. The bile acid sequestrant colesevelam HCl is unique compared with other glucose- and lipid-lowering therapies because it is the only product approved by the US Food and Drug Administration, as an adjunct to diet and exercise, to lower both glucose and low-density lipoprotein cholesterol (LDL-C) in adults with type 2 diabetes and primary hyperlipidaemia, respectively. Furthermore, colesevelam has been shown to have similar glucose- and lipid-lowering efficacy in patients aged <65 years and those aged ≥65 years. Colesevelam was not associated with weight gain, was associated with a low incidence of hypoglycaemia, and can be safely combined with a broad range of glucose-lowering agents (metformin, sulfonylureas and insulin) and lipid-lowering statins. Currently, colesevelam is available in tablet form and as a powder for oral suspension formulation; the latter may be of benefit to elderly patients with swallowing difficulties. As colesevelam has both glucose- and lipid-lowering effects, its use may reduce the drug burden in elderly patients receiving multiple agents for glucose and lipid lowering. Colesevelam may be a valuable treatment option as an add-on to existing glucose- and/or lipid-lowering therapy to help improve haemoglobin A(1c) and to lower LDL-C levels in elderly patients with type 2 diabetes and primary hyperlipidaemia." @default.
• W1971728260 created "2016-06-24" @default.
• W1971728260 creator A5032630989 @default.
• W1971728260 date "2012-05-01" @default.
• W1971728260 modified "2023-10-12" @default.
• W1971728260 title "Glucose and Low-Density Lipoprotein Cholesterol Lowering in Elderly Patients with Type 2 Diabetes" @default.
• W1971728260 cites W12423254 @default.
• W1971728260 cites W1502524639 @default.
• W1971728260 cites W1526891233 @default.
• W1971728260 cites W1971627211 @default.
• W1971728260 cites W1977208802 @default.
• W1971728260 cites W1993580822 @default.
• W1971728260 cites W2027874774 @default.
• W1971728260 cites W2028883953 @default.
• W1971728260 cites W2030751874 @default.
• W1971728260 cites W2031542147 @default.
• W1971728260 cites W2033289265 @default.
• W1971728260 cites W2036747551 @default.
• W1971728260 cites W2037964248 @default.
• W1971728260 cites W2039502953 @default.
• W1971728260 cites W2045923887 @default.
• W1971728260 cites W2046189497 @default.
• W1971728260 cites W2046645679 @default.
• W1971728260 cites W2053365438 @default.
• W1971728260 cites W2058377594 @default.
• W1971728260 cites W2058778081 @default.
• W1971728260 cites W2059078444 @default.
• W1971728260 cites W2061986046 @default.
• W1971728260 cites W2063316925 @default.
• W1971728260 cites W2063363065 @default.
• W1971728260 cites W2071802081 @default.
• W1971728260 cites W2073338924 @default.
• W1971728260 cites W2075169235 @default.
• W1971728260 cites W2077769666 @default.
• W1971728260 cites W2080203935 @default.
• W1971728260 cites W2085737093 @default.
• W1971728260 cites W2088229487 @default.
• W1971728260 cites W2090862011 @default.
• W1971728260 cites W2096466744 @default.
• W1971728260 cites W2097870088 @default.
• W1971728260 cites W2098113018 @default.
• W1971728260 cites W2098289172 @default.
• W1971728260 cites W2099578939 @default.
• W1971728260 cites W2099673402 @default.
• W1971728260 cites W2105719905 @default.
• W1971728260 cites W2106343349 @default.
• W1971728260 cites W2107295258 @default.
• W1971728260 cites W2108646121 @default.
• W1971728260 cites W2114076019 @default.
• W1971728260 cites W2116822087 @default.
• W1971728260 cites W2119065130 @default.
• W1971728260 cites W2125931002 @default.
• W1971728260 cites W2126496418 @default.
• W1971728260 cites W2129750583 @default.
• W1971728260 cites W2130813021 @default.
• W1971728260 cites W2135171522 @default.
• W1971728260 cites W2138109132 @default.
• W1971728260 cites W2139353545 @default.
• W1971728260 cites W2140206052 @default.
• W1971728260 cites W2146901298 @default.
• W1971728260 cites W2149485684 @default.
• W1971728260 cites W2149892283 @default.
• W1971728260 cites W2154719797 @default.
• W1971728260 cites W2155598961 @default.
• W1971728260 cites W2160689800 @default.
• W1971728260 cites W2162992895 @default.
• W1971728260 cites W2166789077 @default.
• W1971728260 cites W2168892366 @default.
• W1971728260 cites W2172201009 @default.
• W1971728260 cites W2322095705 @default.
• W1971728260 cites W2586645431 @default.
• W1971728260 cites W29474508 @default.
• W1971728260 cites W38523360 @default.
• W1971728260 cites W4230870013 @default.
• W1971728260 cites W4238251256 @default.
• W1971728260 cites W4248021162 @default.
• W1971728260 cites W63541796 @default.
• W1971728260 doi "https://doi.org/10.2165/11599290-000000000-00000" @default.
• W1971728260 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3586066" @default.
• W1971728260 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22530704" @default.
• W1971728260 hasPublicationYear "2012" @default.
• W1971728260 type Work @default.
• W1971728260 sameAs 1971728260 @default.
• W1971728260 citedByCount "8" @default.
• W1971728260 countsByYear W19717282602013 @default.
• W1971728260 countsByYear W19717282602014 @default.
• W1971728260 countsByYear W19717282602015 @default.
• W1971728260 countsByYear W19717282602017 @default.
• W1971728260 countsByYear W19717282602018 @default.
• W1971728260 crossrefType "journal-article" @default.
• W1971728260 hasAuthorship W1971728260A5032630989 @default.
• W1971728260 hasBestOaLocation W19717282601 @default.
• W1971728260 hasConcept C126322002 @default.
• W1971728260 hasConcept C134018914 @default.
• W1971728260 hasConcept C197934379 @default.
• W1971728260 hasConcept C2777180221 @default.
• W1971728260 hasConcept C2908647359 @default.
• W1971728260 hasConcept C2910068830 @default.

• next